Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-22-022669

Options or other derivatives

  • CEO and President acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TRENARY C RUSSELL III · CEO and President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +500,000 500,000 D
Loading xslF345X03/doc4.xml…